Anderson Schock
Stock Analyst at B. Riley Securities
(0.28)
# 4,135
Out of 5,182 analysts
9
Total ratings
25%
Success rate
-20.63%
Average return
Main Sectors:
Stocks Rated by Anderson Schock
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BEAT HeartBeam | Initiates: Buy | $4 | $0.92 | +336.78% | 1 | Mar 31, 2026 | |
| OPRX OptimizeRx | Reiterates: Buy | $28 → $11 | $7.20 | +52.78% | 1 | Mar 6, 2026 | |
| SPOK Spok Holdings | Downgrades: Neutral | $21 → $14 | $11.48 | +21.95% | 1 | Feb 26, 2026 | |
| MBOT Microbot Medical | Initiates: Buy | $5 | $2.30 | +117.39% | 1 | Feb 10, 2026 | |
| XGN Exagen | Reiterates: Buy | $18 → $8 | $3.00 | +167.11% | 3 | Jan 30, 2026 | |
| VREX Varex Imaging | Reiterates: Buy | $16 | $11.97 | +33.67% | 1 | Nov 19, 2025 | |
| INGN Inogen | Initiates: Buy | $14 | $6.95 | +101.44% | 1 | Jun 16, 2025 |
HeartBeam
Mar 31, 2026
Initiates: Buy
Price Target: $4
Current: $0.92
Upside: +336.78%
OptimizeRx
Mar 6, 2026
Reiterates: Buy
Price Target: $28 → $11
Current: $7.20
Upside: +52.78%
Spok Holdings
Feb 26, 2026
Downgrades: Neutral
Price Target: $21 → $14
Current: $11.48
Upside: +21.95%
Microbot Medical
Feb 10, 2026
Initiates: Buy
Price Target: $5
Current: $2.30
Upside: +117.39%
Exagen
Jan 30, 2026
Reiterates: Buy
Price Target: $18 → $8
Current: $3.00
Upside: +167.11%
Varex Imaging
Nov 19, 2025
Reiterates: Buy
Price Target: $16
Current: $11.97
Upside: +33.67%
Inogen
Jun 16, 2025
Initiates: Buy
Price Target: $14
Current: $6.95
Upside: +101.44%